VikaVitaeLabs™Repair · Product details
BPC-157
20mg · Body Protection Compound-157
Read research and specifications ↓
VikaVitaeLabs.com
VikaVitaeLabs™BPC-157
20mg
Item # VK-BC20
Technical profile
- Product
- BPC-157
- Size
- 20mg
- Item #
- VK-BC20
Research reference
Research on a named molecule describes the published experimental material. It does not verify the contents or performance of this vial.
Identity
BPC-157 is a 15-residue peptide described in the literature by the sequence GEPPPGKPADDAGLV. Confirm the supplied chemical form and sequence for each lot.
Research focus
Published investigations include tendon-cell behavior, ligament injury models and angiogenesis-related signaling. These are distinct experimental settings.
Models and measurements
The cited tendon work combined a rat injury model with cultured tendon fibroblasts. Researchers measured cellular migration and tissue healing endpoints; separate work examined VEGF-linked angiogenesis.
How to interpret the evidence
Animal and cell findings cannot be read as proof of a human healing effect, and they do not substantiate any untested claim about Vika's stock.
Selected primary studies
- Staresinic and colleagues, 2003 ↗Studied Achilles tendon healing in rats and behavior of cultured tendon fibroblasts.
- BPC-157 angiogenesis study, 2010 ↗Investigated angiogenesis and VEGF-related responses in experimental models.
Draft reference identifiers
From supplied draft material, not lot-certified values. Confirm each identifier against a certificate of analysis.
- CAS
- 137525-51-0
- Formula
- C62H98N16O22
- Sequence
- GEPPPGKPADDAGLV
- Mass
- 1419.5 g/mol
Available sizes
View in catalogFor laboratory research use only. Not for human or veterinary consumption. Lot-specific documentation, when available, governs identity and specifications.